Prolonged Prothrombin Time After Discontinuing Vitamin K Antagonist/Commentary

Both laboratories found a strong presence of LA. Because our patient was using vitamin K antagonists, the patient's plasma was diluted with normal plasma to reduce the effect of medication before performing LA coagulation assays. The influence of antiphospholipid antibodies on INR values is dep...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clinical chemistry (Baltimore, Md.) Md.), 2017-09, Vol.63 (9), p.1442
Hauptverfasser: Schellings, Mark W M, de Maat, Moniek P M, de Lathouder, Sacha, Weerkamp, Floor, Eby, Charles S, Tripodi, Armando
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue 9
container_start_page 1442
container_title Clinical chemistry (Baltimore, Md.)
container_volume 63
creator Schellings, Mark W M
de Maat, Moniek P M
de Lathouder, Sacha
Weerkamp, Floor
Eby, Charles S
Tripodi, Armando
description Both laboratories found a strong presence of LA. Because our patient was using vitamin K antagonists, the patient's plasma was diluted with normal plasma to reduce the effect of medication before performing LA coagulation assays. The influence of antiphospholipid antibodies on INR values is dependent on the reagent used by the clinical laboratory. [...]doubtful results in coagulation testing should always be discussed with a laboratory professional, as was done in this case by the patient himself. [...]they should work to establish an institutional requirement for baseline PT/INR testing before initiating VKA therapy and monitor compliance as a patient safety quality indicator. [...]they should provide a PT mixing study test (1:1 patient plasma and pooled normal plasma) to investigate unexplained prolonged PT results.
doi_str_mv 10.1373/clinchem.2016.267245
format Article
fullrecord <record><control><sourceid>proquest</sourceid><recordid>TN_cdi_proquest_journals_1944539981</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1944539981</sourcerecordid><originalsourceid>FETCH-proquest_journals_19445399813</originalsourceid><addsrcrecordid>eNqNirsKwjAYRoMoWC9v4BBwbk2a9JJRvCAI4iCuUmuskeaPJung25vBB3D6vsM5CM0oSSgr2KJuFdQPqZOU0DxJ8yLlWQ9FNGMkLrOc9lFECBGxoLwYopFzz4C8KPMIHY7WtAYaecPh-Yc1-qoAn5SWeHn30uK1crUBr6BT0OCz8pUOwR4vwVeNAeX8YmW0lgHtZ4IG96p1cvrbMZpvN6fVLn5Z8-6k85en6SwEdaGC84wJUVL2X_UFfvJHUQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1944539981</pqid></control><display><type>article</type><title>Prolonged Prothrombin Time After Discontinuing Vitamin K Antagonist/Commentary</title><source>Oxford University Press Journals All Titles (1996-Current)</source><creator>Schellings, Mark W M ; de Maat, Moniek P M ; de Lathouder, Sacha ; Weerkamp, Floor ; Eby, Charles S ; Tripodi, Armando</creator><creatorcontrib>Schellings, Mark W M ; de Maat, Moniek P M ; de Lathouder, Sacha ; Weerkamp, Floor ; Eby, Charles S ; Tripodi, Armando</creatorcontrib><description>Both laboratories found a strong presence of LA. Because our patient was using vitamin K antagonists, the patient's plasma was diluted with normal plasma to reduce the effect of medication before performing LA coagulation assays. The influence of antiphospholipid antibodies on INR values is dependent on the reagent used by the clinical laboratory. [...]doubtful results in coagulation testing should always be discussed with a laboratory professional, as was done in this case by the patient himself. [...]they should work to establish an institutional requirement for baseline PT/INR testing before initiating VKA therapy and monitor compliance as a patient safety quality indicator. [...]they should provide a PT mixing study test (1:1 patient plasma and pooled normal plasma) to investigate unexplained prolonged PT results.</description><identifier>ISSN: 0009-9147</identifier><identifier>EISSN: 1530-8561</identifier><identifier>DOI: 10.1373/clinchem.2016.267245</identifier><language>eng</language><publisher>Washington: Oxford University Press</publisher><subject>Anticoagulants ; Chemists ; Coagulation ; Colonoscopy ; Glycoproteins ; Immunoglobulins ; Laboratories ; Lupus ; Patients ; Prothrombin ; Thrombosis ; Vitamin K</subject><ispartof>Clinical chemistry (Baltimore, Md.), 2017-09, Vol.63 (9), p.1442</ispartof><rights>Copyright American Association for Clinical Chemistry Sep 2017</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids></links><search><creatorcontrib>Schellings, Mark W M</creatorcontrib><creatorcontrib>de Maat, Moniek P M</creatorcontrib><creatorcontrib>de Lathouder, Sacha</creatorcontrib><creatorcontrib>Weerkamp, Floor</creatorcontrib><creatorcontrib>Eby, Charles S</creatorcontrib><creatorcontrib>Tripodi, Armando</creatorcontrib><title>Prolonged Prothrombin Time After Discontinuing Vitamin K Antagonist/Commentary</title><title>Clinical chemistry (Baltimore, Md.)</title><description>Both laboratories found a strong presence of LA. Because our patient was using vitamin K antagonists, the patient's plasma was diluted with normal plasma to reduce the effect of medication before performing LA coagulation assays. The influence of antiphospholipid antibodies on INR values is dependent on the reagent used by the clinical laboratory. [...]doubtful results in coagulation testing should always be discussed with a laboratory professional, as was done in this case by the patient himself. [...]they should work to establish an institutional requirement for baseline PT/INR testing before initiating VKA therapy and monitor compliance as a patient safety quality indicator. [...]they should provide a PT mixing study test (1:1 patient plasma and pooled normal plasma) to investigate unexplained prolonged PT results.</description><subject>Anticoagulants</subject><subject>Chemists</subject><subject>Coagulation</subject><subject>Colonoscopy</subject><subject>Glycoproteins</subject><subject>Immunoglobulins</subject><subject>Laboratories</subject><subject>Lupus</subject><subject>Patients</subject><subject>Prothrombin</subject><subject>Thrombosis</subject><subject>Vitamin K</subject><issn>0009-9147</issn><issn>1530-8561</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNqNirsKwjAYRoMoWC9v4BBwbk2a9JJRvCAI4iCuUmuskeaPJung25vBB3D6vsM5CM0oSSgr2KJuFdQPqZOU0DxJ8yLlWQ9FNGMkLrOc9lFECBGxoLwYopFzz4C8KPMIHY7WtAYaecPh-Yc1-qoAn5SWeHn30uK1crUBr6BT0OCz8pUOwR4vwVeNAeX8YmW0lgHtZ4IG96p1cvrbMZpvN6fVLn5Z8-6k85en6SwEdaGC84wJUVL2X_UFfvJHUQ</recordid><startdate>20170901</startdate><enddate>20170901</enddate><creator>Schellings, Mark W M</creator><creator>de Maat, Moniek P M</creator><creator>de Lathouder, Sacha</creator><creator>Weerkamp, Floor</creator><creator>Eby, Charles S</creator><creator>Tripodi, Armando</creator><general>Oxford University Press</general><scope>3V.</scope><scope>4U-</scope><scope>7QO</scope><scope>7RV</scope><scope>7TM</scope><scope>7U7</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88I</scope><scope>8AO</scope><scope>8C1</scope><scope>8FD</scope><scope>8FE</scope><scope>8FG</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABJCF</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>BHPHI</scope><scope>BKSAR</scope><scope>C1K</scope><scope>CCPQU</scope><scope>D1I</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>M2P</scope><scope>NAPCQ</scope><scope>P64</scope><scope>PCBAR</scope><scope>PDBOC</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>Q9U</scope><scope>RC3</scope><scope>S0X</scope></search><sort><creationdate>20170901</creationdate><title>Prolonged Prothrombin Time After Discontinuing Vitamin K Antagonist/Commentary</title><author>Schellings, Mark W M ; de Maat, Moniek P M ; de Lathouder, Sacha ; Weerkamp, Floor ; Eby, Charles S ; Tripodi, Armando</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-proquest_journals_19445399813</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Anticoagulants</topic><topic>Chemists</topic><topic>Coagulation</topic><topic>Colonoscopy</topic><topic>Glycoproteins</topic><topic>Immunoglobulins</topic><topic>Laboratories</topic><topic>Lupus</topic><topic>Patients</topic><topic>Prothrombin</topic><topic>Thrombosis</topic><topic>Vitamin K</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Schellings, Mark W M</creatorcontrib><creatorcontrib>de Maat, Moniek P M</creatorcontrib><creatorcontrib>de Lathouder, Sacha</creatorcontrib><creatorcontrib>Weerkamp, Floor</creatorcontrib><creatorcontrib>Eby, Charles S</creatorcontrib><creatorcontrib>Tripodi, Armando</creatorcontrib><collection>ProQuest Central (Corporate)</collection><collection>University Readers</collection><collection>Biotechnology Research Abstracts</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Nucleic Acids Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Materials Science &amp; Engineering Collection</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>Technology Collection</collection><collection>Natural Science Collection</collection><collection>Earth, Atmospheric &amp; Aquatic Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Materials Science Collection</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Materials Science Database</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Science Database</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Earth, Atmospheric &amp; Aquatic Science Database</collection><collection>Materials Science Collection</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central Basic</collection><collection>Genetics Abstracts</collection><collection>SIRS Editorial</collection><jtitle>Clinical chemistry (Baltimore, Md.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Schellings, Mark W M</au><au>de Maat, Moniek P M</au><au>de Lathouder, Sacha</au><au>Weerkamp, Floor</au><au>Eby, Charles S</au><au>Tripodi, Armando</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Prolonged Prothrombin Time After Discontinuing Vitamin K Antagonist/Commentary</atitle><jtitle>Clinical chemistry (Baltimore, Md.)</jtitle><date>2017-09-01</date><risdate>2017</risdate><volume>63</volume><issue>9</issue><spage>1442</spage><pages>1442-</pages><issn>0009-9147</issn><eissn>1530-8561</eissn><abstract>Both laboratories found a strong presence of LA. Because our patient was using vitamin K antagonists, the patient's plasma was diluted with normal plasma to reduce the effect of medication before performing LA coagulation assays. The influence of antiphospholipid antibodies on INR values is dependent on the reagent used by the clinical laboratory. [...]doubtful results in coagulation testing should always be discussed with a laboratory professional, as was done in this case by the patient himself. [...]they should work to establish an institutional requirement for baseline PT/INR testing before initiating VKA therapy and monitor compliance as a patient safety quality indicator. [...]they should provide a PT mixing study test (1:1 patient plasma and pooled normal plasma) to investigate unexplained prolonged PT results.</abstract><cop>Washington</cop><pub>Oxford University Press</pub><doi>10.1373/clinchem.2016.267245</doi></addata></record>
fulltext fulltext
identifier ISSN: 0009-9147
ispartof Clinical chemistry (Baltimore, Md.), 2017-09, Vol.63 (9), p.1442
issn 0009-9147
1530-8561
language eng
recordid cdi_proquest_journals_1944539981
source Oxford University Press Journals All Titles (1996-Current)
subjects Anticoagulants
Chemists
Coagulation
Colonoscopy
Glycoproteins
Immunoglobulins
Laboratories
Lupus
Patients
Prothrombin
Thrombosis
Vitamin K
title Prolonged Prothrombin Time After Discontinuing Vitamin K Antagonist/Commentary
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T12%3A34%3A19IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Prolonged%20Prothrombin%20Time%20After%20Discontinuing%20Vitamin%20K%20Antagonist/Commentary&rft.jtitle=Clinical%20chemistry%20(Baltimore,%20Md.)&rft.au=Schellings,%20Mark%20W%20M&rft.date=2017-09-01&rft.volume=63&rft.issue=9&rft.spage=1442&rft.pages=1442-&rft.issn=0009-9147&rft.eissn=1530-8561&rft_id=info:doi/10.1373/clinchem.2016.267245&rft_dat=%3Cproquest%3E1944539981%3C/proquest%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1944539981&rft_id=info:pmid/&rfr_iscdi=true